ASCO: Add-On Ibrutinib Slows Mantle-Cell Lymphoma in Older Adults
Physician’s Briefing Staff
FRIDAY, June 3, 2022 (HealthDay News) -- For older patients with untreated mantle-cell lymphoma, the addition of ibrutinib to…
Browsing Tag
MantleCell
Add-On Ibrutinib Boosts PFS in Untreated, Older Mantle-Cell Lymphoma Patients
CHICAGO -- A combination of chemoimmunotherapy plus ibrutinib (Imbruvica) significantly reduced the risk of disease progression or…